Skip to main content

Table 2 Study assessments and time points

From: Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation

Study Assessments/Testing Baseline Day
-2 0 7 14 21 28 35 42 Next Clinic Visit 100
Demographics (patient-, disease-, and treatment-related) X           
Additional descriptive outcomes     X X X X     X
Socioeconomic status X           
Hospital Anxiety and Depression Scale (HADS) X   X X X X X     
Blood draw for gene expression analysis X X      X     
Pregnancy test for females of child bearing potential X           
Toxicity    X X X X X Xa Xa   
Assessment of adherenceb   X      X    X  
Heart rate and blood pressure X   X X X X X    X  
Myeloma response assessment            X
  1. aPropranolol group only
  2. bAdherence assessed weekly or monthly based on number of pills prescribed